Treatment of a choroidal neovascular membrane in a patient with late-onset retinal degeneration (L-ORD) with intravitreal ranibizumab.
Aye
K H
KH
Gupta
R
R
Talks
S J
SJ
Browning
A C
AC
D017668:Age of Onset; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010211:Papilledema / Q000188:drug therapy; D000069579:Ranibizumab; D012162:Retinal Degeneration / Q000150:complications*; D016896:Treatment Outcome; D014792:Visual Acuity
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069579:Ranibizumab